{"gene":"RGS4","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1996,"finding":"RGS4 (and GAIP) function as GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis by Gi alpha subunits at least 40-fold; all Gi subfamily members tested were substrates, while Gs alpha was not.","method":"In vitro GTPase assay with purified recombinant proteins","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution, replicated across multiple labs","pmids":["8756726"],"is_preprint":false},{"year":1996,"finding":"RGS4 acts catalytically to stimulate GTP hydrolysis by Gi proteins and stabilizes the transition state for GTP hydrolysis, as evidenced by high affinity binding to GDP-AlF4–bound forms of Goa and Gia; it has lower affinity for GTPgammaS- and GDP-bound forms.","method":"Purified recombinant protein biochemical assay, AlF4- binding/transition-state analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with multiple orthogonal assays, replicated","pmids":["8910288"],"is_preprint":false},{"year":1997,"finding":"Crystal structure of RGS4 complexed with Gi alpha1-Mg2+-GDP-AlF4– at 2.8 Å resolution showed the RGS4 core domain binds to the three switch regions of Gi alpha1 without contributing catalytic residues that directly contact GDP or AlF4–, indicating RGS4 catalyzes GTP hydrolysis primarily by stabilizing switch region transition-state conformation; conserved Asn-128 may also interact with the hydrolytic water or Gln-204 side chain.","method":"X-ray crystallography at 2.8 Å resolution","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation, highly cited foundational paper","pmids":["9108480"],"is_preprint":false},{"year":1997,"finding":"RGS4 and GAIP act as GAPs for Gq alpha and block activation of phospholipase C beta by GTPgammaS-Gq alpha; the inhibition of PLC beta is not explained solely by GAP activity but also by occlusion of the effector binding site on Galpha.","method":"In vitro GTPase assay, plasma membrane reconstitution assay with purified proteins","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mechanistic dissection, replicated","pmids":["9012799"],"is_preprint":false},{"year":1997,"finding":"RGS4 inhibits Gq/11-mediated activation of MAPK and phosphoinositide synthesis in COS-7 cells, acting both as a GAP for Gq/11 (binding Galphaq-GDP-AlF4–) and as an effector antagonist competing with PLC for Galpha binding.","method":"Transient transfection and MAPK/inositol phosphate assays in COS-7 cells; AlF4- stimulation in cells overexpressing Galphaq","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — cellular assays with multiple readouts, replicated in parallel by other groups","pmids":["9115254"],"is_preprint":false},{"year":1997,"finding":"Stably expressed RGS4 in mammalian cells attenuated Gi-mediated inhibition of cAMP synthesis and Gq-mediated activation of phospholipase C beta, recapitulating in vitro selectivity in a cellular context.","method":"Stable transfection in mammalian cells, cAMP and PLC assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean cellular reconstitution, replicated","pmids":["9177187"],"is_preprint":false},{"year":1997,"finding":"Mutation of RGS4 residues N88 and L159 (which contact Gi alpha1 in the crystal structure) abolished binding and GAP activity; mutations R167M/A and F168A reduced GAP activity but shifted binding toward the GTPgammaS-bound form, creating RGS antagonists—demonstrating that transition-state stabilization is the predominant mechanism.","method":"Mutational analysis combined with GAP assays and in vivo signaling assays (yeast pheromone pathway)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — structure-guided mutagenesis + biochemical and in vivo assays","pmids":["9371764"],"is_preprint":false},{"year":1998,"finding":"The N-terminal domain of RGS4 (first ~33 aa) confers receptor-selective inhibition of Gq signaling; deletion of this domain eliminates receptor selectivity and reduces potency 10,000-fold; the RGS box alone accelerates GTP hydrolysis while the N-terminus confers high-affinity, receptor-selective inhibition.","method":"In vitro reconstitution with N-terminal deletion mutants; receptor-selective inhibition assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with domain deletion mutagenesis and quantitative functional assays","pmids":["9856989"],"is_preprint":false},{"year":1998,"finding":"Plasma membrane localization is required for RGS4 function in vivo; deletion of the N-terminal 33 aa abolishes both plasma membrane localization and signaling inhibition in yeast; adding a C-terminal membrane-targeting sequence to the truncated RGS4 restores both; the N-terminal 33 aa are sufficient to target GFP to the plasma membrane; RGS4 is palmitoylated at Cys-2 and Cys-12, but palmitoylation is not required for membrane localization in yeast.","method":"Yeast pheromone response assay, GFP fusion live-cell imaging, palmitoylation site mutagenesis, subcellular fractionation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, functional consequence of localization established","pmids":["9576926"],"is_preprint":false},{"year":1998,"finding":"Multiple RGS4 interface residues contribute additively to GAP activity by stabilizing the transition state conformation; Asn-128 is not exclusively required for catalysis, indicating no single RGS4 residue acts as a classical catalytic 'arginine finger', in contrast to Ras GAPs.","method":"Mutational analysis, biochemical binding, and GTPase assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with biochemical and structural correlation","pmids":["9430692"],"is_preprint":false},{"year":1998,"finding":"RGS4 inhibits signaling by group I metabotropic glutamate receptors (mGluR1a and mGluR5a) in Xenopus oocytes, virtually abolishing calcium-dependent chloride currents; it also markedly attenuates mGluR5-mediated inhibition of potassium currents in hippocampal CA1 neurons, at concentrations matching those for PLC inhibition.","method":"Xenopus oocyte electrophysiology, hippocampal neuron patch clamp, reconstituted PLC assay","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple systems and orthogonal electrophysiology/biochemistry assays","pmids":["9437012"],"is_preprint":false},{"year":1998,"finding":"Expression of GTPase-deficient Gi alpha2-Q204L causes translocation of cytoplasmic RGS4 to the plasma membrane, suggesting RGS4 can be recruited to the membrane indirectly by G-protein activation; in the absence of this stimulus, the majority of cellular RGS4 is cytoplasmic.","method":"Subcellular fractionation, co-expression of GTPase-deficient G protein mutant, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional context, single lab","pmids":["9660808"],"is_preprint":false},{"year":1999,"finding":"RGS4 is palmitoylated at a conserved Cys-95 within the RGS domain (autopalmitoylation with palmitoyl-CoA); palmitoylation of Cys-95 inhibits GAP activity 80–100% in solution-based assays but potentiates GAP activity in receptor-G protein proteoliposomes; dual palmitoylation at Cys-2/12 and Cys-95 is inhibitory.","method":"Metabolic [3H]palmitate labeling in Sf9 cells, autopalmitoylation assay, single-turnover and steady-state GTPase assays, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis and multiple GTPase assay formats","pmids":["10608901"],"is_preprint":false},{"year":1999,"finding":"The N-terminal amphipathic helix (residues 12–30) of RGS16 is sufficient for membrane association, and equivalent structural features are conserved in RGS4 and RGS5; hydrophobic residues of the nonpolar face and positively charged residues along the polar/nonpolar interface are required; RGS4/16 are peripheral membrane proteins and membrane association does not require palmitoylation.","method":"Subcellular fractionation, differential centrifugation, site-directed mutagenesis, GFP fusion localization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods, but primary mechanistic characterization done for RGS16 with inference to RGS4","pmids":["10391923"],"is_preprint":false},{"year":1999,"finding":"Transgenic cardiac-specific overexpression of RGS4 markedly reduced ventricular hypertrophy and cardiac fetal gene program induction in response to pressure overload (transverse aortic constriction), establishing RGS4 as a GAP that inhibits the G protein-dependent hypertrophic signaling pathway in vivo.","method":"Transgenic mouse model, hemodynamic measurements, gene expression analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic loss/gain-of-function with defined cardiac phenotype, replicated","pmids":["10487771"],"is_preprint":false},{"year":1999,"finding":"RGS4 inhibits G-protein signaling in cardiomyocytes; Gq-coupled receptor agonist (phenylephrine, endothelin-1)-mediated gene induction and cardiomyocyte hypertrophy are blocked by RGS4 but not by the N128A-RGS4 GAP-dead mutant, demonstrating that GAP activity is required.","method":"Cardiomyocyte transfection, reporter gene assay, point mutant (N128A) functional analysis","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — GAP-dead mutant controls establish mechanism, replicated by complementary transgenic study","pmids":["9918533"],"is_preprint":false},{"year":2000,"finding":"NMR solution structure of free RGS4 reveals a backbone rmsd of 1.94 Å compared with the Galpha-bound crystal structure, demonstrating that RGS4 undergoes an induced conformational change upon binding Gi alpha1, involving a kink in the helix at residues K116–Y119 that reorganizes the binding pocket.","method":"2D/3D heteronuclear NMR spectroscopy, 2871 restraints, comparison with existing X-ray structure","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution NMR structure with functional validation by structural comparison","pmids":["10852703"],"is_preprint":false},{"year":2000,"finding":"RGS4 is arginylated and degraded by the N-end rule pathway in reticulocyte lysate; the degron resides at the N-terminus; Cys-2 must become N-terminal (following Met removal) and is then arginylated, with N-terminal Arg acting as a destabilizing residue recognized by the ubiquitin/proteasome system.","method":"Expression-cloning screen in reticulocyte lysate, radiochemical N-terminal sequencing, site-directed mutagenesis of N-terminal residues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution with sequencing and mutagenesis, foundational mechanistic paper","pmids":["10783390"],"is_preprint":false},{"year":2000,"finding":"RGS4 selectively enhances alpha2A-adrenoreceptor-stimulated GTPase activity of Galpha(o1) and Galpha(i2) but not Galpha(i1) or Galpha(i3), increasing both Vmax and Km for GTP in an enzyme kinetic analysis, demonstrating G protein subtype-selective GAP action in the context of receptor activation.","method":"Receptor-Galpha fusion protein GTPase assay in COS-7 cells, enzyme kinetic analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative kinetic analysis in cellular system, single lab","pmids":["10807934"],"is_preprint":false},{"year":2001,"finding":"RGS4 is required for the agonist concentration-dependent relaxation (voltage-dependent kinetics) of G protein-gated inwardly rectifying K+ (KG/Kir3) channels in Xenopus oocytes; this effect requires the RGS domain and its interaction with pertussis toxin-sensitive Galpha subunits, not Gs-coupled pathways.","method":"Xenopus oocyte electrophysiology, truncation and point mutants of RGS4, selective G protein coupling experiments","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — electrophysiology with mutant dissection and mechanistic specificity","pmids":["11507164"],"is_preprint":false},{"year":2001,"finding":"Dual-transgenic overexpression of RGS4 in Galphaq-40 transgenic hearts normalized fractional shortening, LV dimensions, PKC xi membrane translocation, and fetal gene expression, establishing RGS4 as a Galphaq GAP in the in vivo heart.","method":"Dual transgenic mouse model, echocardiography, Western blot for PKC translocation, gene expression","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — epistasis experiment in vivo with multiple orthogonal phenotypic readouts","pmids":["11162127"],"is_preprint":false},{"year":2002,"finding":"Recombinant RGS4 blunted endothelin-1-stimulated PLC activity in human LV membranes; adenoviral RGS4 overexpression in rabbit ventricular myocytes abolished the inotropic effect of ET-1, implicating upregulated RGS4 in desensitization of Gq/11-mediated signaling in failing myocardium.","method":"Recombinant protein addition to human cardiac membranes (PLC assay), adenoviral gene transfer in isolated cardiomyocytes","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 — functional reconstitution in human tissue and primary cardiomyocytes, single lab","pmids":["12176127"],"is_preprint":false},{"year":2003,"finding":"GFP-RGS4 expressed in HEK293 cells localizes to the cytosol but is selectively recruited to the plasma membrane by coexpression with Galpha(i2) or M2 muscarinic receptor; G protein mutants with reduced RGS affinity do not produce this effect, demonstrating that recruitment involves direct G protein binding and is independent of downstream signaling.","method":"GFP live-cell imaging, subcellular localization, G protein mutant coexpression, steady-state Gi GTPase assay","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional consequence and mechanistic controls, single lab","pmids":["12920194"],"is_preprint":false},{"year":2003,"finding":"Endogenous RGS4 in rat brain and PC12 cells localizes predominantly to membrane fractions (not cytosolic as seen with transfected tagged protein); endogenous RGS4 is a single 27–28 kDa protein and its expression level is strongly controlled by proteolysis.","method":"Subcellular fractionation, Western blot with specific antibodies detecting endogenous protein","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct fractionation of endogenous protein, single lab","pmids":["14604980"],"is_preprint":false},{"year":2005,"finding":"ATE1 Arg-transferase mediates in vivo degradation of RGS4 and RGS5 via the N-end rule pathway; sequential modifications (N-terminal exposure of Cys-2, its oxidation, then arginylation) act as a licensing mechanism before ubiquitin ligases UBR1/UBR2 target RGS4 for proteasomal degradation; hypoxia perturbs this proteolysis; Cys-2 mutants are long-lived in vivo.","method":"ATE1-/- and UBR1/UBR2 knockout mouse cells, pulse-chase protein stability, site-directed mutagenesis, in vivo ubiquitination assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — multiple genetic knockouts + mutagenesis + biochemical reconstitution, replicated concept from prior in vitro work","pmids":["16217033"],"is_preprint":false},{"year":2006,"finding":"GABA(B) receptors, Kir3 channels, Galpha(o), and RGS4 are in close proximity (<100 Å) at the plasma membrane of living HEK293 cells, as demonstrated by FRET between CFP/YFP-tagged proteins; significant FRET (~13%) occurs between RGS4 and GABA(B) R1 or R2 subunits, indicating physical association in a signaling complex.","method":"FRET combined with total internal reflection fluorescence microscopy in live HEK293 cells","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — live-cell FRET with positive and negative controls, single lab","pmids":["17185339"],"is_preprint":false},{"year":2006,"finding":"RGS4 associates with GPCR-Kir3 channel complexes via both its N-terminal domain and RGS domain; unlike RGS3s which acts by 'collision coupling', RGS4 'precouples' to the GPCR-Kir3 complex (with the GPCR as the major RGS4 interaction target), resulting in ~100-fold greater potency in accelerating G protein-dependent Kir3 channel-gating kinetics without attenuation of current amplitude.","method":"Co-immunoprecipitation from CHO-K1 cells, deletion and chimeric RGS constructs, electrophysiology (Kir3 channel gating kinetics)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus domain mapping plus functional electrophysiology, single lab","pmids":["16973624"],"is_preprint":false},{"year":2006,"finding":"PKA and PKG phosphorylate RGS4 at Ser-52, causing its translocation from cytosol to plasma membrane, enhanced association with Galpha(q)-GTP, and increased intrinsic Galpha(q) GTPase activity; expression of RGS4(S52A) blocks PKA/PKG-induced increases in GTPase activity and inhibition of PI hydrolysis, demonstrating phosphorylation of RGS4 as a mechanism by which PKA/PKG inhibit Gq-mediated PLC-beta1 activity.","method":"In vitro phosphorylation, subcellular fractionation, co-immunoprecipitation, phosphorylation-dead mutant (S52A), PLC/GTPase assays in gastric smooth muscle cells","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis + kinase assay + functional cellular readout, multiple orthogonal methods","pmids":["16885398"],"is_preprint":false},{"year":2006,"finding":"The small molecule CCG-4986 inhibits RGS4 by covalently modifying Cys-132 on the Galpha-interaction face of the RGS domain; mutation of Cys-132 abolishes CCG-4986 sensitivity; the mechanism was confirmed by mass spectrometry identifying a 153-Da fragment covalently attached to surface-exposed cysteines.","method":"Surface plasmon resonance, FRET assay, single-turnover GTPase assay, site-directed mutagenesis, mass spectrometry","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — covalent mechanism established by MS + mutagenesis + multiple binding assays","pmids":["17660054"],"is_preprint":false},{"year":2007,"finding":"N-terminal residues of RGS4 control proteasomal degradation in HEK293 cells; stabilizing mutation C2S enhances RGS4 expression and function; the N-end rule degradation pathway strongly controls cellular RGS4 levels and, consequently, its GAP function.","method":"N-terminal mutagenesis, protein stability assays, GPCR signaling functional assays in HEK293 cells","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional readout, single lab","pmids":["17220356"],"is_preprint":false},{"year":2007,"finding":"IL-1beta upregulates RGS4 expression in colonic smooth muscle via the canonical IKK2/IkappaBalpha/NF-kappaB pathway; siRNA knockdown of RGS4 blocked IL-1beta's inhibitory effect on acetylcholine-stimulated PLC-beta activation and initial contraction, confirming RGS4 as the mediator of IL-1beta-induced inhibition of smooth muscle contraction.","method":"siRNA knockdown, IKK2 inhibitors, NF-kappaB reporter assay, PLC-beta assay, smooth muscle contraction assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA with pathway inhibitors and functional contraction readout, single lab","pmids":["18260825"],"is_preprint":false},{"year":2008,"finding":"RGS4-null mice show enhanced bradycardic responses to parasympathetic agonists and decreased GIRK channel desensitization (IKACh) in sinoatrial node myocytes, establishing RGS4 as a regulator of parasympathetic tone in the sinoatrial node by inhibiting Gi/o signaling and IKACh kinetics.","method":"RGS4-null mouse model, in vivo heart rate telemetry, ex vivo perfused heart, SAN myocyte patch clamp electrophysiology","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple complementary in vivo and ex vivo readouts","pmids":["18658048"],"is_preprint":false},{"year":2009,"finding":"RGS4 directly interacts with the delta-opioid receptor (via C-tail and third intracellular domain) but not with the mu-opioid receptor, as shown by co-immunoprecipitation; endogenous RGS4 knockdown specifically increases delta-opioid receptor agonist (SNC80) potency and MAPK activation, with no change in mu-opioid (morphine) responses.","method":"Stable shRNA knockdown of endogenous RGS4, co-immunoprecipitation with receptor chimeras, cAMP and MAPK assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — endogenous protein knockdown + co-IP + receptor chimera mapping + functional assays","pmids":["19416973"],"is_preprint":false},{"year":2010,"finding":"RGS4 is a potent negative regulator of M3 muscarinic receptor (M3R)/Gq-mediated augmentation of glucose-stimulated insulin secretion in pancreatic beta-cells; siRNA knockdown of RGS4 in MIN6 cells and deletion in mouse islets greatly enhances M3R-mediated calcium release and insulin secretion; beta-cell-specific RGS4 deletion in vivo increases plasma insulin and reduces blood glucose after muscarinic agonist treatment.","method":"siRNA knockdown in MIN6 cells, RGS4-deficient mouse islets, beta-cell-specific knockout mice, calcium imaging, insulin secretion assay, in vivo glucose/insulin measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models + functional assays in vitro and in vivo, single lab","pmids":["20385802"],"is_preprint":false},{"year":2011,"finding":"Opioid agonist (DAMGO, DPDPE) treatment causes proteasomal and lysosomal degradation of RGS4 protein in SH-SY5Y cells via a ubiquitin-dependent mechanism; polyubiquitinated RGS4 accumulates with proteasome inhibitors; MOR agonist-induced RGS4 degradation is blocked by pertussis toxin, indicating Gi/o dependence; downstream effect is cross-talk between delta-OR and M3 muscarinic receptor signaling through RGS4.","method":"Proteasome inhibitors (MG132, lactacystin), pertussis toxin, Western blot, ubiquitination assay, functional signaling assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with proteasome inhibitors and pertussis toxin, single lab","pmids":["21209077"],"is_preprint":false},{"year":2012,"finding":"RGS4 is a key link between D2/A2A receptor cAMP/PKA signaling and endocannabinoid (eCB) mobilization in striatal indirect-pathway MSNs; RGS4-/- mice show normal eCB-LTD after dopamine depletion and significantly less motor impairment in the 6-OHDA Parkinson's model, establishing RGS4 as mediating dopaminergic regulation of eCB-LTD.","method":"RGS4 knockout mouse, electrophysiology (LTD recording), 6-OHDA mouse model, pharmacological dissection of signaling pathways","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with defined synaptic plasticity and behavioral phenotypes, multiple orthogonal methods","pmids":["22284188"],"is_preprint":false},{"year":2012,"finding":"Neurabin scaffolds RGS4 with the adenosine A1 receptor (A1R) to form a complex that attenuates A1R signaling; loss of neurabin enhances A1R signaling and anti-seizure protection; RGS4 inhibitor administered in vivo attenuates seizure severity, demonstrating the A1R/neurabin/RGS4 complex as a functional regulatory unit.","method":"Co-immunoprecipitation (complex assembly), neurabin knockout mouse, RGS4 inhibitor in vivo, kainate seizure model","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus genetic KO plus pharmacological inhibition in vivo, single lab","pmids":["22357852"],"is_preprint":false},{"year":2013,"finding":"NO production from endothelial cells induces proteasomal degradation of RGS4, thereby relieving repression of the Gbeta-gamma/PI3K-gamma/AKT/mTORC1 pathway and stimulating cardiomyocyte growth; NOS inhibitor L-NAME attenuates RGS4 degradation; eNOS knockout mice do not develop myocardial hypertrophy upon PlGF overexpression; transgenic RGS4 expression prevents hypertrophy.","method":"Transgenic mouse models (PlGF, RGS4, eNOS KO), NOS inhibitor, proteasomal degradation assay, AKT/mTORC1 signaling analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models with convergent evidence, defined molecular pathway","pmids":["23454748"],"is_preprint":false},{"year":2013,"finding":"Rab5 activation decreases RGS4 plasma membrane levels and increases its endosomal targeting; Rab7 promotes TGN association of RGS4; Rab11 mediates RGS4 recycling to the plasma membrane (Cys-12 is required for Rab11-mediated trafficking); inhibition of Rab11 decreases RGS4 function as inhibitor of M1R activity without affecting M1R/Gq localization or function.","method":"Rab GTPase dominant-active/dominant-negative constructs, live-cell imaging, co-localization with endosomal markers, functional M1R signaling assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple Rab constructs with functional consequence, single lab","pmids":["23733193"],"is_preprint":false},{"year":2014,"finding":"RGS4 forms distinct G protein-dependent complexes with PAR1: RGS4 interaction with PAR1 requires Galpha(o) (not other Galpha), demonstrated by BRET; purified PAR1 intracellular third loop directly binds purified RGS4; RGS4 selectively inhibits PAR1/Gao-mediated MAPK/ERK signaling but not RhoA signaling.","method":"BRET in live COS-7 cells, pulldown with purified GST-fusion proteins, functional MAPK/ERK and RhoA signaling assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — BRET plus direct pulldown plus functional signaling assays, single lab","pmids":["24743392"],"is_preprint":false},{"year":2015,"finding":"RGS4 deletion results in predisposition to atrial fibrillation; RGS4-/- atrial cells show increased Ca2+ spark frequency and abnormal spontaneous Ca2+ release; the mechanism involves enhanced Galpha(q/11)-IP3 pathway activity leading to abnormal Ca2+ release and abnormal electrical events.","method":"RGS4-/- mouse model, in vivo atrial burst pacing, isolated atrial cell Ca2+ imaging, multielectrode array","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple complementary functional readouts and defined pathway","pmids":["26088132"],"is_preprint":false},{"year":2015,"finding":"The thiadiazolidinone inhibitor CCG-203769 selectively inhibits RGS4 (8- to >5000-fold selectivity over other RGS proteins, 300-fold over GSK-3beta); it enhances Galphaq-dependent Ca2+ signaling in an RGS4-dependent manner, enhances Galphai-dependent delta-OR inhibition of cAMP, potentiates muscarinic bradycardia in vivo, and reverses raclopride-induced akinesia in mice (Parkinson's model).","method":"Biochemical selectivity panel, Ca2+ signaling assay in RGS4-expressing cells, in vivo bradycardia and akinesia assays, cAMP assay in SH-SY5Y cells","journal":"ACS chemical neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vitro and in vivo assays with RGS4-dependent specificity controls","pmids":["25844489"],"is_preprint":false}],"current_model":"RGS4 is a GTPase-activating protein (GAP) whose RGS core domain binds to the switch regions of activated Galpha subunits (Gi and Gq families) and stabilizes their GTP hydrolysis transition state—without itself contributing catalytic residues—while its N-terminal amphipathic domain confers high-affinity, receptor-selective inhibition and plasma membrane targeting via palmitoylation and hydrophobic interactions; RGS4 protein levels are regulated post-translationally by sequential N-terminal Cys-2 oxidation, arginylation by ATE1, and ubiquitin-proteasomal degradation via UBR1/UBR2 (N-end rule pathway), as well as by PKA/PKG phosphorylation at Ser-52 that promotes membrane translocation and GAP activity; RGS4 localizes to plasma membrane and endosomes (trafficking regulated by Rab5, Rab7, and Rab11) and associates with receptor-Kir3 channel signaling complexes through direct GPCR interaction, modulating cardiac pacemaking, striatal synaptic plasticity, pancreatic insulin secretion, smooth muscle contraction, and chronic pain signaling."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing RGS4 as a GAP for Gi-family Gα subunits answered the fundamental question of what biochemical activity RGS proteins possess, revealing they accelerate GTP hydrolysis ≥40-fold and prefer the transition-state conformation of Gα.","evidence":"In vitro GTPase assays with purified recombinant proteins and AlF4⁻ transition-state trapping","pmids":["8756726","8910288"],"confidence":"High","gaps":["Selectivity among Gi subfamily members not fully resolved","Mechanism of transition-state stabilization not yet structurally defined"]},{"year":1997,"claim":"The crystal structure of the RGS4–Giα1 complex revealed that the RGS domain contacts all three Gα switch regions without contributing catalytic residues to the active site, establishing transition-state stabilization as the dominant catalytic mechanism and distinguishing it from Ras GAPs.","evidence":"X-ray crystallography at 2.8 Å resolution of RGS4–Giα1·GDP·AlF4⁻ complex, validated by structure-guided mutagenesis","pmids":["9108480","9371764","9430692"],"confidence":"High","gaps":["Whether Asn-128 directly contacts catalytic water remained debated","Structure of free RGS4 and induced-fit changes unknown"]},{"year":1997,"claim":"Demonstrating that RGS4 also acts as a GAP for Gαq and blocks PLC-β activation—partly by effector-site occlusion—expanded its substrate range beyond Gi to include Gq-mediated signaling pathways.","evidence":"In vitro GTPase and PLC reconstitution assays, cellular MAPK and inositol phosphate assays in COS-7 cells","pmids":["9012799","9115254","9177187"],"confidence":"High","gaps":["Relative contribution of GAP versus effector antagonism in intact cells unclear","G12/13 family substrates not tested"]},{"year":1998,"claim":"The N-terminal amphipathic domain was shown to be essential for plasma membrane targeting, receptor-selective inhibition, and high-potency GAP function, separating the catalytic core from the targeting/selectivity module.","evidence":"N-terminal deletion mutants in reconstituted systems and yeast pheromone assay; GFP localization; palmitoylation site mutagenesis","pmids":["9856989","9576926"],"confidence":"High","gaps":["Whether palmitoylation is required in mammalian cells remained unresolved","Structural basis of receptor selectivity unknown"]},{"year":1998,"claim":"RGS4 was shown to inhibit metabotropic glutamate receptor signaling in neurons, providing the first evidence of its physiological role in regulating Gq-coupled neurotransmission.","evidence":"Xenopus oocyte electrophysiology for mGluR1a/5a; patch clamp in hippocampal CA1 neurons","pmids":["9437012"],"confidence":"High","gaps":["Endogenous RGS4 contribution versus other RGS family members not dissected","In vivo neuronal role not yet tested"]},{"year":1999,"claim":"Cardiac-specific transgenic overexpression demonstrated that RGS4 inhibits pressure-overload-induced ventricular hypertrophy in vivo, establishing its physiological role as a brake on Gq-dependent hypertrophic signaling in the heart.","evidence":"Transgenic mouse model with transverse aortic constriction; hemodynamics and fetal gene expression analysis; GAP-dead N128A mutant as negative control in cardiomyocytes","pmids":["10487771","9918533"],"confidence":"High","gaps":["Loss-of-function cardiac phenotype not yet examined","Specific Gα substrates in cardiomyocytes not identified"]},{"year":2000,"claim":"NMR structure of free RGS4 revealed an induced-fit conformational change upon Gα binding, and the N-end rule degradation pathway was identified as the mechanism controlling RGS4 protein turnover, linking its Cys-2 residue to arginylation and proteasomal targeting.","evidence":"Solution NMR spectroscopy; expression-cloning screen in reticulocyte lysate with N-terminal sequencing and mutagenesis","pmids":["10852703","10783390"],"confidence":"High","gaps":["Identity of the E3 ubiquitin ligase not yet established","Whether Cys-2 oxidation is regulated in vivo unknown"]},{"year":2005,"claim":"Genetic identification of ATE1, UBR1, and UBR2 as the arginyl-transferase and E3 ligases targeting RGS4 completed the molecular pathway of N-end rule degradation and revealed oxygen/NO-dependent Cys-2 oxidation as a regulatory switch.","evidence":"ATE1−/−, UBR1/UBR2 knockout mouse cells; pulse-chase stability assays; in vivo ubiquitination","pmids":["16217033"],"confidence":"High","gaps":["Physiological oxygen sensing context not fully defined","Whether other post-translational modifications cooperate with N-end rule pathway"]},{"year":2006,"claim":"RGS4 was found to pre-couple with GPCR–Kir3 channel complexes via direct receptor interaction and to be regulated by PKA/PKG phosphorylation at Ser-52, revealing how scaffolding and kinase signaling tune its GAP activity at the plasma membrane.","evidence":"Co-immunoprecipitation and FRET in live cells; in vitro phosphorylation; S52A mutant; GTPase/PLC assays in smooth muscle cells","pmids":["16973624","17185339","16885398"],"confidence":"High","gaps":["Structural basis of GPCR–RGS4 interaction not resolved","Whether phosphorylation and palmitoylation are coordinated"]},{"year":2008,"claim":"RGS4 knockout mice revealed enhanced parasympathetic bradycardia and impaired IKACh desensitization in sinoatrial node myocytes, establishing RGS4 as a non-redundant regulator of cardiac pacemaking.","evidence":"RGS4−/− mouse; in vivo telemetry; ex vivo perfused heart; SAN myocyte patch clamp","pmids":["18658048"],"confidence":"High","gaps":["Redundancy with other cardiac RGS proteins (RGS6, RGS10) not fully dissected","Human cardiac relevance not directly tested"]},{"year":2010,"claim":"Beta-cell-specific RGS4 deletion demonstrated that RGS4 tonically suppresses M3 muscarinic receptor/Gq-mediated insulin secretion, identifying it as a physiological regulator of glucose homeostasis.","evidence":"siRNA in MIN6 cells; RGS4-deficient islets; beta-cell-specific knockout mice; calcium imaging and insulin secretion in vivo","pmids":["20385802"],"confidence":"High","gaps":["Whether RGS4 regulates GLP-1R or other incretin receptor pathways in beta cells","Compensatory RGS family member expression not assessed"]},{"year":2012,"claim":"RGS4 knockout restored endocannabinoid-dependent long-term depression in dopamine-depleted striatum and reduced motor impairment in a Parkinson's model, establishing RGS4 as a link between D2/A2A receptor signaling and synaptic plasticity relevant to basal ganglia function.","evidence":"RGS4−/− mouse; electrophysiological LTD recording; 6-OHDA Parkinson's model; pharmacological pathway dissection","pmids":["22284188"],"confidence":"High","gaps":["Cell-type-specific RGS4 contribution (direct vs indirect pathway MSNs) not isolated","Downstream eCB synthesis mechanism not fully defined"]},{"year":2013,"claim":"Rab GTPase-dependent trafficking of RGS4 between plasma membrane and endosomes was mapped, and NO-induced proteasomal degradation of RGS4 was shown to derepress Gβγ/PI3Kγ/AKT signaling to promote cardiomyocyte hypertrophy, integrating membrane trafficking and degradation as regulatory mechanisms.","evidence":"Dominant-active/negative Rab constructs with live-cell imaging; transgenic PlGF/RGS4/eNOS-KO mouse models; NOS inhibitor studies","pmids":["23733193","23454748"],"confidence":"Medium","gaps":["Rab-mediated trafficking studied primarily with overexpressed constructs","Whether endosomal RGS4 retains GAP activity unknown"]},{"year":2015,"claim":"RGS4 deletion predisposed to atrial fibrillation via enhanced Gαq/11-IP3-mediated Ca²⁺ release, and a selective small-molecule RGS4 inhibitor validated RGS4 as a druggable target in cardiac and neurological disease models.","evidence":"RGS4−/− mouse with atrial burst pacing and Ca²⁺ imaging; CCG-203769 selectivity panel; in vivo bradycardia and akinesia assays","pmids":["26088132","25844489"],"confidence":"High","gaps":["Long-term in vivo pharmacology and off-target effects of CCG-203769 not characterized","Whether RGS4 loss-of-function variants cause human arrhythmia unknown"]},{"year":null,"claim":"The structural basis of RGS4's direct interaction with GPCRs, the precise mechanism by which Cys-2 oxidation is sensed in vivo, and whether RGS4 functions at endosomes remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of RGS4 bound to any GPCR","Oxygen/NO sensing mechanism for Cys-2 oxidation not reconstituted in defined system","Functional significance of endosomal RGS4 pool not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3,4,5,7,9,15,18,19]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,1,2,6,9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,11,22,23,27,38]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,22,27]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[38]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,4,5,7,10,19,26,27,32,33,35]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[10,19,25,26,31,35,36]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[17,24,29,34,37]}],"complexes":["GPCR-Kir3 channel signaling complex","A1R/neurabin/RGS4 complex"],"partners":["GNAI1","GNAI2","GNAO1","GNAQ","KCNJ3","ATE1","UBR1","PPP1R9A"],"other_free_text":[]},"mechanistic_narrative":"RGS4 is a GTPase-activating protein (GAP) that accelerates GTP hydrolysis by Gαi and Gαq family subunits, thereby terminating heterotrimeric G protein signaling downstream of multiple GPCRs. Its RGS core domain binds the switch regions of activated Gα subunits and stabilizes the transition-state conformation without contributing catalytic residues directly to the hydrolysis site, while also occluding the effector-binding surface to antagonize phospholipase C-β activation [PMID:9108480, PMID:9012799]. The N-terminal amphipathic domain confers receptor-selective inhibition, plasma membrane targeting, and direct interaction with GPCRs such as δ-opioid and GABAB receptors within pre-assembled receptor–Kir3 channel signaling complexes, and its protein levels are tightly controlled by sequential N-terminal Cys-2 oxidation, ATE1-mediated arginylation, and UBR1/UBR2-dependent proteasomal degradation via the N-end rule pathway [PMID:9856989, PMID:16973624, PMID:16217033]. Through these mechanisms, RGS4 regulates cardiac parasympathetic pacemaking and hypertrophic signaling, striatal endocannabinoid-dependent synaptic plasticity, pancreatic β-cell insulin secretion, and smooth muscle contraction [PMID:18658048, PMID:22284188, PMID:20385802, PMID:18260825]."},"prefetch_data":{"uniprot":{"accession":"P49798","full_name":"Regulator of G-protein signaling 4","aliases":[],"length_aa":205,"mass_kda":23.3,"function":"Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(z)-alpha is inhibited by phosphorylation of the G-protein. Activity on G(z)-alpha and G(i)-alpha-1 is inhibited by palmitoylation of the G-protein","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P49798/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS4","total_profiled":1310},"omim":[{"mim_id":"611392","title":"2-@AMINOETHANETHIOL DIOXYGENASE; ADO","url":"https://www.omim.org/entry/611392"},{"mim_id":"607120","title":"PHOSPHOLIPASE C, BETA-1; PLCB1","url":"https://www.omim.org/entry/607120"},{"mim_id":"607103","title":"ARGINYLTRANSFERASE 1; ATE1","url":"https://www.omim.org/entry/607103"},{"mim_id":"602516","title":"REGULATOR OF G PROTEIN SIGNALING 4; RGS4","url":"https://www.omim.org/entry/602516"},{"mim_id":"181500","title":"SCHIZOPHRENIA; SCZD","url":"https://www.omim.org/entry/181500"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":192.4}],"url":"https://www.proteinatlas.org/search/RGS4"},"hgnc":{"alias_symbol":[],"prev_symbol":["SCZD9"]},"alphafold":{"accession":"P49798","domains":[{"cath_id":"1.10.167.10","chopping":"52-177","consensus_level":"medium","plddt":96.4439,"start":52,"end":177}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49798","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49798-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49798-F1-predicted_aligned_error_v6.png","plddt_mean":78.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS4","jax_strain_url":"https://www.jax.org/strain/search?query=RGS4"},"sequence":{"accession":"P49798","fasta_url":"https://rest.uniprot.org/uniprotkb/P49798.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49798/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49798"}},"corpus_meta":[{"pmid":"9108480","id":"PMC_9108480","title":"Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis.","date":"1997","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9108480","citation_count":702,"is_preprint":false},{"pmid":"8756726","id":"PMC_8756726","title":"GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits.","date":"1996","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8756726","citation_count":676,"is_preprint":false},{"pmid":"11326297","id":"PMC_11326297","title":"Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11326297","citation_count":350,"is_preprint":false},{"pmid":"9012799","id":"PMC_9012799","title":"RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9012799","citation_count":330,"is_preprint":false},{"pmid":"8910288","id":"PMC_8910288","title":"The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910288","citation_count":294,"is_preprint":false},{"pmid":"12023979","id":"PMC_12023979","title":"Association and linkage analyses of RGS4 polymorphisms in schizophrenia.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12023979","citation_count":269,"is_preprint":false},{"pmid":"16217033","id":"PMC_16217033","title":"RGS4 and RGS5 are in vivo substrates of the N-end rule pathway.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16217033","citation_count":229,"is_preprint":false},{"pmid":"9856989","id":"PMC_9856989","title":"The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9856989","citation_count":212,"is_preprint":false},{"pmid":"10487771","id":"PMC_10487771","title":"RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.","date":"1999","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10487771","citation_count":167,"is_preprint":false},{"pmid":"9177187","id":"PMC_9177187","title":"Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9177187","citation_count":149,"is_preprint":false},{"pmid":"22284188","id":"PMC_22284188","title":"RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.","date":"2012","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/22284188","citation_count":148,"is_preprint":false},{"pmid":"10783390","id":"PMC_10783390","title":"RGS4 is arginylated and degraded by the N-end rule pathway in vitro.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10783390","citation_count":137,"is_preprint":false},{"pmid":"9576926","id":"PMC_9576926","title":"Plasma membrane localization is required for RGS4 function in Saccharomyces cerevisiae.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9576926","citation_count":130,"is_preprint":false},{"pmid":"9115254","id":"PMC_9115254","title":"RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9115254","citation_count":129,"is_preprint":false},{"pmid":"9437012","id":"PMC_9437012","title":"RGS4 inhibits signaling by group I metabotropic glutamate receptors.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9437012","citation_count":120,"is_preprint":false},{"pmid":"12920194","id":"PMC_12920194","title":"Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12920194","citation_count":114,"is_preprint":false},{"pmid":"17006672","id":"PMC_17006672","title":"Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17006672","citation_count":114,"is_preprint":false},{"pmid":"9430692","id":"PMC_9430692","title":"Mechanism of RGS4, a GTPase-activating protein for G protein alpha subunits.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430692","citation_count":108,"is_preprint":false},{"pmid":"17012620","id":"PMC_17012620","title":"Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17012620","citation_count":105,"is_preprint":false},{"pmid":"18658048","id":"PMC_18658048","title":"RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node.","date":"2008","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18658048","citation_count":103,"is_preprint":false},{"pmid":"14755443","id":"PMC_14755443","title":"Confirming RGS4 as a susceptibility gene for schizophrenia.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14755443","citation_count":101,"is_preprint":false},{"pmid":"14732600","id":"PMC_14732600","title":"Support for RGS4 as a susceptibility gene for schizophrenia.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14732600","citation_count":100,"is_preprint":false},{"pmid":"12176127","id":"PMC_12176127","title":"Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure.","date":"2002","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/12176127","citation_count":96,"is_preprint":false},{"pmid":"17185339","id":"PMC_17185339","title":"Evidence for association of GABA(B) receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17185339","citation_count":95,"is_preprint":false},{"pmid":"10391923","id":"PMC_10391923","title":"The membrane association domain of RGS16 contains unique amphipathic features that are conserved in RGS4 and RGS5.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10391923","citation_count":89,"is_preprint":false},{"pmid":"10608901","id":"PMC_10608901","title":"Palmitoylation of a conserved cysteine in the regulator of G protein signaling (RGS) domain modulates the GTPase-activating activity of RGS4 and RGS10.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608901","citation_count":88,"is_preprint":false},{"pmid":"15870291","id":"PMC_15870291","title":"Generation and characterization of Rgs4 mutant mice.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15870291","citation_count":84,"is_preprint":false},{"pmid":"15381923","id":"PMC_15381923","title":"Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients.","date":"2005","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15381923","citation_count":82,"is_preprint":false},{"pmid":"17301167","id":"PMC_17301167","title":"Allelic variation in RGS4 impacts functional and structural connectivity in the human brain.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17301167","citation_count":82,"is_preprint":false},{"pmid":"16120478","id":"PMC_16120478","title":"Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16120478","citation_count":81,"is_preprint":false},{"pmid":"10233999","id":"PMC_10233999","title":"Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10233999","citation_count":81,"is_preprint":false},{"pmid":"16565965","id":"PMC_16565965","title":"Regional alterations in RGS4 protein in schizophrenia.","date":"2006","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16565965","citation_count":78,"is_preprint":false},{"pmid":"16860780","id":"PMC_16860780","title":"Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4).","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16860780","citation_count":77,"is_preprint":false},{"pmid":"17220356","id":"PMC_17220356","title":"N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17220356","citation_count":75,"is_preprint":false},{"pmid":"12270694","id":"PMC_12270694","title":"Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment.","date":"2002","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/12270694","citation_count":75,"is_preprint":false},{"pmid":"16631129","id":"PMC_16631129","title":"Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16631129","citation_count":71,"is_preprint":false},{"pmid":"9660808","id":"PMC_9660808","title":"Expression of GTPase-deficient Gialpha2 results in translocation of cytoplasmic RGS4 to the plasma membrane.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9660808","citation_count":70,"is_preprint":false},{"pmid":"15274033","id":"PMC_15274033","title":"Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15274033","citation_count":70,"is_preprint":false},{"pmid":"9918533","id":"PMC_9918533","title":"RGS4 inhibits G-protein signaling in cardiomyocytes.","date":"1999","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/9918533","citation_count":69,"is_preprint":false},{"pmid":"16885398","id":"PMC_16885398","title":"Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16885398","citation_count":68,"is_preprint":false},{"pmid":"23454748","id":"PMC_23454748","title":"NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23454748","citation_count":68,"is_preprint":false},{"pmid":"20385802","id":"PMC_20385802","title":"RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20385802","citation_count":67,"is_preprint":false},{"pmid":"17408693","id":"PMC_17408693","title":"Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction.","date":"2007","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17408693","citation_count":67,"is_preprint":false},{"pmid":"10936173","id":"PMC_10936173","title":"Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10936173","citation_count":64,"is_preprint":false},{"pmid":"11428836","id":"PMC_11428836","title":"Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure.","date":"2001","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/11428836","citation_count":63,"is_preprint":false},{"pmid":"9515003","id":"PMC_9515003","title":"RGS3 and RGS4 are GTPase activating proteins in the heart.","date":"1998","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/9515003","citation_count":61,"is_preprint":false},{"pmid":"14604980","id":"PMC_14604980","title":"Differentially regulated expression of endogenous RGS4 and RGS7.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14604980","citation_count":61,"is_preprint":false},{"pmid":"15055445","id":"PMC_15055445","title":"Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.","date":"2004","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15055445","citation_count":61,"is_preprint":false},{"pmid":"15090051","id":"PMC_15090051","title":"Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15090051","citation_count":56,"is_preprint":false},{"pmid":"11162127","id":"PMC_11162127","title":"RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice.","date":"2001","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11162127","citation_count":55,"is_preprint":false},{"pmid":"17410640","id":"PMC_17410640","title":"The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia.","date":"2007","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/17410640","citation_count":55,"is_preprint":false},{"pmid":"15182322","id":"PMC_15182322","title":"Regional expression of RGS4 mRNA in human brain.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15182322","citation_count":55,"is_preprint":false},{"pmid":"10807934","id":"PMC_10807934","title":"The regulator of G protein signaling RGS4 selectively enhances alpha 2A-adreoreceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10807934","citation_count":55,"is_preprint":false},{"pmid":"17220354","id":"PMC_17220354","title":"RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia.","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17220354","citation_count":54,"is_preprint":false},{"pmid":"15548600","id":"PMC_15548600","title":"Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15548600","citation_count":54,"is_preprint":false},{"pmid":"14627646","id":"PMC_14627646","title":"Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14627646","citation_count":50,"is_preprint":false},{"pmid":"9371764","id":"PMC_9371764","title":"Inhibition of regulator of G protein signaling function by two mutant RGS4 proteins.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9371764","citation_count":50,"is_preprint":false},{"pmid":"19416973","id":"PMC_19416973","title":"Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19416973","citation_count":50,"is_preprint":false},{"pmid":"11906535","id":"PMC_11906535","title":"Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain.","date":"2002","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11906535","citation_count":48,"is_preprint":false},{"pmid":"17588543","id":"PMC_17588543","title":"Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17588543","citation_count":46,"is_preprint":false},{"pmid":"17660054","id":"PMC_17660054","title":"The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Galpha-interaction face.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17660054","citation_count":46,"is_preprint":false},{"pmid":"17959727","id":"PMC_17959727","title":"Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17959727","citation_count":45,"is_preprint":false},{"pmid":"16973624","id":"PMC_16973624","title":"RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16973624","citation_count":44,"is_preprint":false},{"pmid":"15660667","id":"PMC_15660667","title":"Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil.","date":"2005","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/15660667","citation_count":43,"is_preprint":false},{"pmid":"25844489","id":"PMC_25844489","title":"Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors.","date":"2015","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25844489","citation_count":41,"is_preprint":false},{"pmid":"17071056","id":"PMC_17071056","title":"Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia.","date":"2006","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17071056","citation_count":41,"is_preprint":false},{"pmid":"16905560","id":"PMC_16905560","title":"RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16905560","citation_count":40,"is_preprint":false},{"pmid":"12181442","id":"PMC_12181442","title":"Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G(i).","date":"2002","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12181442","citation_count":39,"is_preprint":false},{"pmid":"21215802","id":"PMC_21215802","title":"Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.","date":"2011","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21215802","citation_count":38,"is_preprint":false},{"pmid":"31587286","id":"PMC_31587286","title":"lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31587286","citation_count":37,"is_preprint":false},{"pmid":"22562250","id":"PMC_22562250","title":"Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22562250","citation_count":37,"is_preprint":false},{"pmid":"9425263","id":"PMC_9425263","title":"Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9425263","citation_count":37,"is_preprint":false},{"pmid":"19041089","id":"PMC_19041089","title":"Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19041089","citation_count":36,"is_preprint":false},{"pmid":"32392739","id":"PMC_32392739","title":"Targeting RGS4 Ablates Glioblastoma Proliferation.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32392739","citation_count":36,"is_preprint":false},{"pmid":"10852703","id":"PMC_10852703","title":"NMR structure of free RGS4 reveals an induced conformational change upon binding Galpha.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10852703","citation_count":36,"is_preprint":false},{"pmid":"19369446","id":"PMC_19369446","title":"Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19369446","citation_count":36,"is_preprint":false},{"pmid":"22357852","id":"PMC_22357852","title":"Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22357852","citation_count":35,"is_preprint":false},{"pmid":"18260825","id":"PMC_18260825","title":"Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18260825","citation_count":35,"is_preprint":false},{"pmid":"11755131","id":"PMC_11755131","title":"Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu- or kappa-opioid receptors.","date":"2001","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11755131","citation_count":34,"is_preprint":false},{"pmid":"16082709","id":"PMC_16082709","title":"Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16082709","citation_count":34,"is_preprint":false},{"pmid":"11507164","id":"PMC_11507164","title":"Interaction between the RGS domain of RGS4 with G protein alpha subunits mediates the voltage-dependent relaxation of the G protein-gated potassium channel.","date":"2001","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11507164","citation_count":34,"is_preprint":false},{"pmid":"18207159","id":"PMC_18207159","title":"RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18207159","citation_count":34,"is_preprint":false},{"pmid":"17515439","id":"PMC_17515439","title":"Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia.","date":"2007","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/17515439","citation_count":32,"is_preprint":false},{"pmid":"24318880","id":"PMC_24318880","title":"RGS6, but not RGS4, is the dominant regulator of G protein signaling (RGS) modulator of the parasympathetic regulation of mouse heart rate.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24318880","citation_count":31,"is_preprint":false},{"pmid":"16358332","id":"PMC_16358332","title":"Low mRNA levels of RGS4 splice variants in Alzheimer's disease: association between a rare haplotype and decreased mRNA expression.","date":"2006","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16358332","citation_count":31,"is_preprint":false},{"pmid":"18204343","id":"PMC_18204343","title":"RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.","date":"2008","source":"Journal of clinical psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18204343","citation_count":31,"is_preprint":false},{"pmid":"23052218","id":"PMC_23052218","title":"Zebrafish rgs4 is essential for motility and axonogenesis mediated by Akt signaling.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/23052218","citation_count":30,"is_preprint":false},{"pmid":"16176390","id":"PMC_16176390","title":"Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia.","date":"2005","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/16176390","citation_count":30,"is_preprint":false},{"pmid":"23733193","id":"PMC_23733193","title":"Rab family proteins regulate the endosomal trafficking and function of RGS4.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23733193","citation_count":29,"is_preprint":false},{"pmid":"11744024","id":"PMC_11744024","title":"Endotoxin induces desensitization of cardiac endothelin-1 receptor signaling by increased expression of RGS4 and RGS16.","date":"2002","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/11744024","citation_count":29,"is_preprint":false},{"pmid":"22193724","id":"PMC_22193724","title":"RGS4 overexpression in the rat dorsal striatum modulates mGluR5- and amphetamine-mediated behavior and signaling.","date":"2011","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22193724","citation_count":28,"is_preprint":false},{"pmid":"35781563","id":"PMC_35781563","title":"Bisphenol-A impairs synaptic formation and function by RGS4-mediated regulation of BDNF signaling in the cerebral cortex.","date":"2022","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/35781563","citation_count":28,"is_preprint":false},{"pmid":"19153107","id":"PMC_19153107","title":"Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex.","date":"2009","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/19153107","citation_count":28,"is_preprint":false},{"pmid":"15009535","id":"PMC_15009535","title":"Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors.","date":"2004","source":"The journal of peptide research : official journal of the American Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/15009535","citation_count":28,"is_preprint":false},{"pmid":"21209077","id":"PMC_21209077","title":"Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21209077","citation_count":27,"is_preprint":false},{"pmid":"26088132","id":"PMC_26088132","title":"Absence of the Regulator of G-protein Signaling, RGS4, Predisposes to Atrial Fibrillation and Is Associated with Abnormal Calcium Handling.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26088132","citation_count":25,"is_preprint":false},{"pmid":"25695583","id":"PMC_25695583","title":"Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.","date":"2015","source":"Anesthesia and analgesia","url":"https://pubmed.ncbi.nlm.nih.gov/25695583","citation_count":25,"is_preprint":false},{"pmid":"31308097","id":"PMC_31308097","title":"RGS4 Maintains Chronic Pain Symptoms in Rodent Models.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31308097","citation_count":25,"is_preprint":false},{"pmid":"24743392","id":"PMC_24743392","title":"Regulator of G protein signaling 2 (RGS2) and RGS4 form distinct G protein-dependent complexes with protease activated-receptor 1 (PAR1) in live cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24743392","citation_count":25,"is_preprint":false},{"pmid":"16791139","id":"PMC_16791139","title":"Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16791139","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51779,"output_tokens":9939,"usd":0.152211},"stage2":{"model":"claude-opus-4-6","input_tokens":13873,"output_tokens":3744,"usd":0.244448},"total_usd":0.396659,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"RGS4 (and GAIP) function as GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis by Gi alpha subunits at least 40-fold; all Gi subfamily members tested were substrates, while Gs alpha was not.\",\n      \"method\": \"In vitro GTPase assay with purified recombinant proteins\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution, replicated across multiple labs\",\n      \"pmids\": [\"8756726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RGS4 acts catalytically to stimulate GTP hydrolysis by Gi proteins and stabilizes the transition state for GTP hydrolysis, as evidenced by high affinity binding to GDP-AlF4–bound forms of Goa and Gia; it has lower affinity for GTPgammaS- and GDP-bound forms.\",\n      \"method\": \"Purified recombinant protein biochemical assay, AlF4- binding/transition-state analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with multiple orthogonal assays, replicated\",\n      \"pmids\": [\"8910288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Crystal structure of RGS4 complexed with Gi alpha1-Mg2+-GDP-AlF4– at 2.8 Å resolution showed the RGS4 core domain binds to the three switch regions of Gi alpha1 without contributing catalytic residues that directly contact GDP or AlF4–, indicating RGS4 catalyzes GTP hydrolysis primarily by stabilizing switch region transition-state conformation; conserved Asn-128 may also interact with the hydrolytic water or Gln-204 side chain.\",\n      \"method\": \"X-ray crystallography at 2.8 Å resolution\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation, highly cited foundational paper\",\n      \"pmids\": [\"9108480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RGS4 and GAIP act as GAPs for Gq alpha and block activation of phospholipase C beta by GTPgammaS-Gq alpha; the inhibition of PLC beta is not explained solely by GAP activity but also by occlusion of the effector binding site on Galpha.\",\n      \"method\": \"In vitro GTPase assay, plasma membrane reconstitution assay with purified proteins\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mechanistic dissection, replicated\",\n      \"pmids\": [\"9012799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RGS4 inhibits Gq/11-mediated activation of MAPK and phosphoinositide synthesis in COS-7 cells, acting both as a GAP for Gq/11 (binding Galphaq-GDP-AlF4–) and as an effector antagonist competing with PLC for Galpha binding.\",\n      \"method\": \"Transient transfection and MAPK/inositol phosphate assays in COS-7 cells; AlF4- stimulation in cells overexpressing Galphaq\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cellular assays with multiple readouts, replicated in parallel by other groups\",\n      \"pmids\": [\"9115254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Stably expressed RGS4 in mammalian cells attenuated Gi-mediated inhibition of cAMP synthesis and Gq-mediated activation of phospholipase C beta, recapitulating in vitro selectivity in a cellular context.\",\n      \"method\": \"Stable transfection in mammalian cells, cAMP and PLC assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean cellular reconstitution, replicated\",\n      \"pmids\": [\"9177187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Mutation of RGS4 residues N88 and L159 (which contact Gi alpha1 in the crystal structure) abolished binding and GAP activity; mutations R167M/A and F168A reduced GAP activity but shifted binding toward the GTPgammaS-bound form, creating RGS antagonists—demonstrating that transition-state stabilization is the predominant mechanism.\",\n      \"method\": \"Mutational analysis combined with GAP assays and in vivo signaling assays (yeast pheromone pathway)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-guided mutagenesis + biochemical and in vivo assays\",\n      \"pmids\": [\"9371764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The N-terminal domain of RGS4 (first ~33 aa) confers receptor-selective inhibition of Gq signaling; deletion of this domain eliminates receptor selectivity and reduces potency 10,000-fold; the RGS box alone accelerates GTP hydrolysis while the N-terminus confers high-affinity, receptor-selective inhibition.\",\n      \"method\": \"In vitro reconstitution with N-terminal deletion mutants; receptor-selective inhibition assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with domain deletion mutagenesis and quantitative functional assays\",\n      \"pmids\": [\"9856989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Plasma membrane localization is required for RGS4 function in vivo; deletion of the N-terminal 33 aa abolishes both plasma membrane localization and signaling inhibition in yeast; adding a C-terminal membrane-targeting sequence to the truncated RGS4 restores both; the N-terminal 33 aa are sufficient to target GFP to the plasma membrane; RGS4 is palmitoylated at Cys-2 and Cys-12, but palmitoylation is not required for membrane localization in yeast.\",\n      \"method\": \"Yeast pheromone response assay, GFP fusion live-cell imaging, palmitoylation site mutagenesis, subcellular fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, functional consequence of localization established\",\n      \"pmids\": [\"9576926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Multiple RGS4 interface residues contribute additively to GAP activity by stabilizing the transition state conformation; Asn-128 is not exclusively required for catalysis, indicating no single RGS4 residue acts as a classical catalytic 'arginine finger', in contrast to Ras GAPs.\",\n      \"method\": \"Mutational analysis, biochemical binding, and GTPase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with biochemical and structural correlation\",\n      \"pmids\": [\"9430692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RGS4 inhibits signaling by group I metabotropic glutamate receptors (mGluR1a and mGluR5a) in Xenopus oocytes, virtually abolishing calcium-dependent chloride currents; it also markedly attenuates mGluR5-mediated inhibition of potassium currents in hippocampal CA1 neurons, at concentrations matching those for PLC inhibition.\",\n      \"method\": \"Xenopus oocyte electrophysiology, hippocampal neuron patch clamp, reconstituted PLC assay\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple systems and orthogonal electrophysiology/biochemistry assays\",\n      \"pmids\": [\"9437012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Expression of GTPase-deficient Gi alpha2-Q204L causes translocation of cytoplasmic RGS4 to the plasma membrane, suggesting RGS4 can be recruited to the membrane indirectly by G-protein activation; in the absence of this stimulus, the majority of cellular RGS4 is cytoplasmic.\",\n      \"method\": \"Subcellular fractionation, co-expression of GTPase-deficient G protein mutant, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional context, single lab\",\n      \"pmids\": [\"9660808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS4 is palmitoylated at a conserved Cys-95 within the RGS domain (autopalmitoylation with palmitoyl-CoA); palmitoylation of Cys-95 inhibits GAP activity 80–100% in solution-based assays but potentiates GAP activity in receptor-G protein proteoliposomes; dual palmitoylation at Cys-2/12 and Cys-95 is inhibitory.\",\n      \"method\": \"Metabolic [3H]palmitate labeling in Sf9 cells, autopalmitoylation assay, single-turnover and steady-state GTPase assays, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis and multiple GTPase assay formats\",\n      \"pmids\": [\"10608901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The N-terminal amphipathic helix (residues 12–30) of RGS16 is sufficient for membrane association, and equivalent structural features are conserved in RGS4 and RGS5; hydrophobic residues of the nonpolar face and positively charged residues along the polar/nonpolar interface are required; RGS4/16 are peripheral membrane proteins and membrane association does not require palmitoylation.\",\n      \"method\": \"Subcellular fractionation, differential centrifugation, site-directed mutagenesis, GFP fusion localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods, but primary mechanistic characterization done for RGS16 with inference to RGS4\",\n      \"pmids\": [\"10391923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Transgenic cardiac-specific overexpression of RGS4 markedly reduced ventricular hypertrophy and cardiac fetal gene program induction in response to pressure overload (transverse aortic constriction), establishing RGS4 as a GAP that inhibits the G protein-dependent hypertrophic signaling pathway in vivo.\",\n      \"method\": \"Transgenic mouse model, hemodynamic measurements, gene expression analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic loss/gain-of-function with defined cardiac phenotype, replicated\",\n      \"pmids\": [\"10487771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS4 inhibits G-protein signaling in cardiomyocytes; Gq-coupled receptor agonist (phenylephrine, endothelin-1)-mediated gene induction and cardiomyocyte hypertrophy are blocked by RGS4 but not by the N128A-RGS4 GAP-dead mutant, demonstrating that GAP activity is required.\",\n      \"method\": \"Cardiomyocyte transfection, reporter gene assay, point mutant (N128A) functional analysis\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — GAP-dead mutant controls establish mechanism, replicated by complementary transgenic study\",\n      \"pmids\": [\"9918533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NMR solution structure of free RGS4 reveals a backbone rmsd of 1.94 Å compared with the Galpha-bound crystal structure, demonstrating that RGS4 undergoes an induced conformational change upon binding Gi alpha1, involving a kink in the helix at residues K116–Y119 that reorganizes the binding pocket.\",\n      \"method\": \"2D/3D heteronuclear NMR spectroscopy, 2871 restraints, comparison with existing X-ray structure\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution NMR structure with functional validation by structural comparison\",\n      \"pmids\": [\"10852703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS4 is arginylated and degraded by the N-end rule pathway in reticulocyte lysate; the degron resides at the N-terminus; Cys-2 must become N-terminal (following Met removal) and is then arginylated, with N-terminal Arg acting as a destabilizing residue recognized by the ubiquitin/proteasome system.\",\n      \"method\": \"Expression-cloning screen in reticulocyte lysate, radiochemical N-terminal sequencing, site-directed mutagenesis of N-terminal residues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with sequencing and mutagenesis, foundational mechanistic paper\",\n      \"pmids\": [\"10783390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS4 selectively enhances alpha2A-adrenoreceptor-stimulated GTPase activity of Galpha(o1) and Galpha(i2) but not Galpha(i1) or Galpha(i3), increasing both Vmax and Km for GTP in an enzyme kinetic analysis, demonstrating G protein subtype-selective GAP action in the context of receptor activation.\",\n      \"method\": \"Receptor-Galpha fusion protein GTPase assay in COS-7 cells, enzyme kinetic analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative kinetic analysis in cellular system, single lab\",\n      \"pmids\": [\"10807934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RGS4 is required for the agonist concentration-dependent relaxation (voltage-dependent kinetics) of G protein-gated inwardly rectifying K+ (KG/Kir3) channels in Xenopus oocytes; this effect requires the RGS domain and its interaction with pertussis toxin-sensitive Galpha subunits, not Gs-coupled pathways.\",\n      \"method\": \"Xenopus oocyte electrophysiology, truncation and point mutants of RGS4, selective G protein coupling experiments\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with mutant dissection and mechanistic specificity\",\n      \"pmids\": [\"11507164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Dual-transgenic overexpression of RGS4 in Galphaq-40 transgenic hearts normalized fractional shortening, LV dimensions, PKC xi membrane translocation, and fetal gene expression, establishing RGS4 as a Galphaq GAP in the in vivo heart.\",\n      \"method\": \"Dual transgenic mouse model, echocardiography, Western blot for PKC translocation, gene expression\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis experiment in vivo with multiple orthogonal phenotypic readouts\",\n      \"pmids\": [\"11162127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Recombinant RGS4 blunted endothelin-1-stimulated PLC activity in human LV membranes; adenoviral RGS4 overexpression in rabbit ventricular myocytes abolished the inotropic effect of ET-1, implicating upregulated RGS4 in desensitization of Gq/11-mediated signaling in failing myocardium.\",\n      \"method\": \"Recombinant protein addition to human cardiac membranes (PLC assay), adenoviral gene transfer in isolated cardiomyocytes\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution in human tissue and primary cardiomyocytes, single lab\",\n      \"pmids\": [\"12176127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GFP-RGS4 expressed in HEK293 cells localizes to the cytosol but is selectively recruited to the plasma membrane by coexpression with Galpha(i2) or M2 muscarinic receptor; G protein mutants with reduced RGS affinity do not produce this effect, demonstrating that recruitment involves direct G protein binding and is independent of downstream signaling.\",\n      \"method\": \"GFP live-cell imaging, subcellular localization, G protein mutant coexpression, steady-state Gi GTPase assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence and mechanistic controls, single lab\",\n      \"pmids\": [\"12920194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Endogenous RGS4 in rat brain and PC12 cells localizes predominantly to membrane fractions (not cytosolic as seen with transfected tagged protein); endogenous RGS4 is a single 27–28 kDa protein and its expression level is strongly controlled by proteolysis.\",\n      \"method\": \"Subcellular fractionation, Western blot with specific antibodies detecting endogenous protein\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation of endogenous protein, single lab\",\n      \"pmids\": [\"14604980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ATE1 Arg-transferase mediates in vivo degradation of RGS4 and RGS5 via the N-end rule pathway; sequential modifications (N-terminal exposure of Cys-2, its oxidation, then arginylation) act as a licensing mechanism before ubiquitin ligases UBR1/UBR2 target RGS4 for proteasomal degradation; hypoxia perturbs this proteolysis; Cys-2 mutants are long-lived in vivo.\",\n      \"method\": \"ATE1-/- and UBR1/UBR2 knockout mouse cells, pulse-chase protein stability, site-directed mutagenesis, in vivo ubiquitination assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple genetic knockouts + mutagenesis + biochemical reconstitution, replicated concept from prior in vitro work\",\n      \"pmids\": [\"16217033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GABA(B) receptors, Kir3 channels, Galpha(o), and RGS4 are in close proximity (<100 Å) at the plasma membrane of living HEK293 cells, as demonstrated by FRET between CFP/YFP-tagged proteins; significant FRET (~13%) occurs between RGS4 and GABA(B) R1 or R2 subunits, indicating physical association in a signaling complex.\",\n      \"method\": \"FRET combined with total internal reflection fluorescence microscopy in live HEK293 cells\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live-cell FRET with positive and negative controls, single lab\",\n      \"pmids\": [\"17185339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RGS4 associates with GPCR-Kir3 channel complexes via both its N-terminal domain and RGS domain; unlike RGS3s which acts by 'collision coupling', RGS4 'precouples' to the GPCR-Kir3 complex (with the GPCR as the major RGS4 interaction target), resulting in ~100-fold greater potency in accelerating G protein-dependent Kir3 channel-gating kinetics without attenuation of current amplitude.\",\n      \"method\": \"Co-immunoprecipitation from CHO-K1 cells, deletion and chimeric RGS constructs, electrophysiology (Kir3 channel gating kinetics)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus domain mapping plus functional electrophysiology, single lab\",\n      \"pmids\": [\"16973624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKA and PKG phosphorylate RGS4 at Ser-52, causing its translocation from cytosol to plasma membrane, enhanced association with Galpha(q)-GTP, and increased intrinsic Galpha(q) GTPase activity; expression of RGS4(S52A) blocks PKA/PKG-induced increases in GTPase activity and inhibition of PI hydrolysis, demonstrating phosphorylation of RGS4 as a mechanism by which PKA/PKG inhibit Gq-mediated PLC-beta1 activity.\",\n      \"method\": \"In vitro phosphorylation, subcellular fractionation, co-immunoprecipitation, phosphorylation-dead mutant (S52A), PLC/GTPase assays in gastric smooth muscle cells\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis + kinase assay + functional cellular readout, multiple orthogonal methods\",\n      \"pmids\": [\"16885398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The small molecule CCG-4986 inhibits RGS4 by covalently modifying Cys-132 on the Galpha-interaction face of the RGS domain; mutation of Cys-132 abolishes CCG-4986 sensitivity; the mechanism was confirmed by mass spectrometry identifying a 153-Da fragment covalently attached to surface-exposed cysteines.\",\n      \"method\": \"Surface plasmon resonance, FRET assay, single-turnover GTPase assay, site-directed mutagenesis, mass spectrometry\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — covalent mechanism established by MS + mutagenesis + multiple binding assays\",\n      \"pmids\": [\"17660054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"N-terminal residues of RGS4 control proteasomal degradation in HEK293 cells; stabilizing mutation C2S enhances RGS4 expression and function; the N-end rule degradation pathway strongly controls cellular RGS4 levels and, consequently, its GAP function.\",\n      \"method\": \"N-terminal mutagenesis, protein stability assays, GPCR signaling functional assays in HEK293 cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional readout, single lab\",\n      \"pmids\": [\"17220356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IL-1beta upregulates RGS4 expression in colonic smooth muscle via the canonical IKK2/IkappaBalpha/NF-kappaB pathway; siRNA knockdown of RGS4 blocked IL-1beta's inhibitory effect on acetylcholine-stimulated PLC-beta activation and initial contraction, confirming RGS4 as the mediator of IL-1beta-induced inhibition of smooth muscle contraction.\",\n      \"method\": \"siRNA knockdown, IKK2 inhibitors, NF-kappaB reporter assay, PLC-beta assay, smooth muscle contraction assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA with pathway inhibitors and functional contraction readout, single lab\",\n      \"pmids\": [\"18260825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RGS4-null mice show enhanced bradycardic responses to parasympathetic agonists and decreased GIRK channel desensitization (IKACh) in sinoatrial node myocytes, establishing RGS4 as a regulator of parasympathetic tone in the sinoatrial node by inhibiting Gi/o signaling and IKACh kinetics.\",\n      \"method\": \"RGS4-null mouse model, in vivo heart rate telemetry, ex vivo perfused heart, SAN myocyte patch clamp electrophysiology\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple complementary in vivo and ex vivo readouts\",\n      \"pmids\": [\"18658048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RGS4 directly interacts with the delta-opioid receptor (via C-tail and third intracellular domain) but not with the mu-opioid receptor, as shown by co-immunoprecipitation; endogenous RGS4 knockdown specifically increases delta-opioid receptor agonist (SNC80) potency and MAPK activation, with no change in mu-opioid (morphine) responses.\",\n      \"method\": \"Stable shRNA knockdown of endogenous RGS4, co-immunoprecipitation with receptor chimeras, cAMP and MAPK assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — endogenous protein knockdown + co-IP + receptor chimera mapping + functional assays\",\n      \"pmids\": [\"19416973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RGS4 is a potent negative regulator of M3 muscarinic receptor (M3R)/Gq-mediated augmentation of glucose-stimulated insulin secretion in pancreatic beta-cells; siRNA knockdown of RGS4 in MIN6 cells and deletion in mouse islets greatly enhances M3R-mediated calcium release and insulin secretion; beta-cell-specific RGS4 deletion in vivo increases plasma insulin and reduces blood glucose after muscarinic agonist treatment.\",\n      \"method\": \"siRNA knockdown in MIN6 cells, RGS4-deficient mouse islets, beta-cell-specific knockout mice, calcium imaging, insulin secretion assay, in vivo glucose/insulin measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models + functional assays in vitro and in vivo, single lab\",\n      \"pmids\": [\"20385802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Opioid agonist (DAMGO, DPDPE) treatment causes proteasomal and lysosomal degradation of RGS4 protein in SH-SY5Y cells via a ubiquitin-dependent mechanism; polyubiquitinated RGS4 accumulates with proteasome inhibitors; MOR agonist-induced RGS4 degradation is blocked by pertussis toxin, indicating Gi/o dependence; downstream effect is cross-talk between delta-OR and M3 muscarinic receptor signaling through RGS4.\",\n      \"method\": \"Proteasome inhibitors (MG132, lactacystin), pertussis toxin, Western blot, ubiquitination assay, functional signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with proteasome inhibitors and pertussis toxin, single lab\",\n      \"pmids\": [\"21209077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RGS4 is a key link between D2/A2A receptor cAMP/PKA signaling and endocannabinoid (eCB) mobilization in striatal indirect-pathway MSNs; RGS4-/- mice show normal eCB-LTD after dopamine depletion and significantly less motor impairment in the 6-OHDA Parkinson's model, establishing RGS4 as mediating dopaminergic regulation of eCB-LTD.\",\n      \"method\": \"RGS4 knockout mouse, electrophysiology (LTD recording), 6-OHDA mouse model, pharmacological dissection of signaling pathways\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined synaptic plasticity and behavioral phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"22284188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Neurabin scaffolds RGS4 with the adenosine A1 receptor (A1R) to form a complex that attenuates A1R signaling; loss of neurabin enhances A1R signaling and anti-seizure protection; RGS4 inhibitor administered in vivo attenuates seizure severity, demonstrating the A1R/neurabin/RGS4 complex as a functional regulatory unit.\",\n      \"method\": \"Co-immunoprecipitation (complex assembly), neurabin knockout mouse, RGS4 inhibitor in vivo, kainate seizure model\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus genetic KO plus pharmacological inhibition in vivo, single lab\",\n      \"pmids\": [\"22357852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NO production from endothelial cells induces proteasomal degradation of RGS4, thereby relieving repression of the Gbeta-gamma/PI3K-gamma/AKT/mTORC1 pathway and stimulating cardiomyocyte growth; NOS inhibitor L-NAME attenuates RGS4 degradation; eNOS knockout mice do not develop myocardial hypertrophy upon PlGF overexpression; transgenic RGS4 expression prevents hypertrophy.\",\n      \"method\": \"Transgenic mouse models (PlGF, RGS4, eNOS KO), NOS inhibitor, proteasomal degradation assay, AKT/mTORC1 signaling analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models with convergent evidence, defined molecular pathway\",\n      \"pmids\": [\"23454748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rab5 activation decreases RGS4 plasma membrane levels and increases its endosomal targeting; Rab7 promotes TGN association of RGS4; Rab11 mediates RGS4 recycling to the plasma membrane (Cys-12 is required for Rab11-mediated trafficking); inhibition of Rab11 decreases RGS4 function as inhibitor of M1R activity without affecting M1R/Gq localization or function.\",\n      \"method\": \"Rab GTPase dominant-active/dominant-negative constructs, live-cell imaging, co-localization with endosomal markers, functional M1R signaling assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple Rab constructs with functional consequence, single lab\",\n      \"pmids\": [\"23733193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RGS4 forms distinct G protein-dependent complexes with PAR1: RGS4 interaction with PAR1 requires Galpha(o) (not other Galpha), demonstrated by BRET; purified PAR1 intracellular third loop directly binds purified RGS4; RGS4 selectively inhibits PAR1/Gao-mediated MAPK/ERK signaling but not RhoA signaling.\",\n      \"method\": \"BRET in live COS-7 cells, pulldown with purified GST-fusion proteins, functional MAPK/ERK and RhoA signaling assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — BRET plus direct pulldown plus functional signaling assays, single lab\",\n      \"pmids\": [\"24743392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RGS4 deletion results in predisposition to atrial fibrillation; RGS4-/- atrial cells show increased Ca2+ spark frequency and abnormal spontaneous Ca2+ release; the mechanism involves enhanced Galpha(q/11)-IP3 pathway activity leading to abnormal Ca2+ release and abnormal electrical events.\",\n      \"method\": \"RGS4-/- mouse model, in vivo atrial burst pacing, isolated atrial cell Ca2+ imaging, multielectrode array\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple complementary functional readouts and defined pathway\",\n      \"pmids\": [\"26088132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The thiadiazolidinone inhibitor CCG-203769 selectively inhibits RGS4 (8- to >5000-fold selectivity over other RGS proteins, 300-fold over GSK-3beta); it enhances Galphaq-dependent Ca2+ signaling in an RGS4-dependent manner, enhances Galphai-dependent delta-OR inhibition of cAMP, potentiates muscarinic bradycardia in vivo, and reverses raclopride-induced akinesia in mice (Parkinson's model).\",\n      \"method\": \"Biochemical selectivity panel, Ca2+ signaling assay in RGS4-expressing cells, in vivo bradycardia and akinesia assays, cAMP assay in SH-SY5Y cells\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo assays with RGS4-dependent specificity controls\",\n      \"pmids\": [\"25844489\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS4 is a GTPase-activating protein (GAP) whose RGS core domain binds to the switch regions of activated Galpha subunits (Gi and Gq families) and stabilizes their GTP hydrolysis transition state—without itself contributing catalytic residues—while its N-terminal amphipathic domain confers high-affinity, receptor-selective inhibition and plasma membrane targeting via palmitoylation and hydrophobic interactions; RGS4 protein levels are regulated post-translationally by sequential N-terminal Cys-2 oxidation, arginylation by ATE1, and ubiquitin-proteasomal degradation via UBR1/UBR2 (N-end rule pathway), as well as by PKA/PKG phosphorylation at Ser-52 that promotes membrane translocation and GAP activity; RGS4 localizes to plasma membrane and endosomes (trafficking regulated by Rab5, Rab7, and Rab11) and associates with receptor-Kir3 channel signaling complexes through direct GPCR interaction, modulating cardiac pacemaking, striatal synaptic plasticity, pancreatic insulin secretion, smooth muscle contraction, and chronic pain signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RGS4 is a GTPase-activating protein (GAP) that accelerates GTP hydrolysis by Gαi and Gαq family subunits, thereby terminating heterotrimeric G protein signaling downstream of multiple GPCRs. Its RGS core domain binds the switch regions of activated Gα subunits and stabilizes the transition-state conformation without contributing catalytic residues directly to the hydrolysis site, while also occluding the effector-binding surface to antagonize phospholipase C-β activation [PMID:9108480, PMID:9012799]. The N-terminal amphipathic domain confers receptor-selective inhibition, plasma membrane targeting, and direct interaction with GPCRs such as δ-opioid and GABAB receptors within pre-assembled receptor–Kir3 channel signaling complexes, and its protein levels are tightly controlled by sequential N-terminal Cys-2 oxidation, ATE1-mediated arginylation, and UBR1/UBR2-dependent proteasomal degradation via the N-end rule pathway [PMID:9856989, PMID:16973624, PMID:16217033]. Through these mechanisms, RGS4 regulates cardiac parasympathetic pacemaking and hypertrophic signaling, striatal endocannabinoid-dependent synaptic plasticity, pancreatic β-cell insulin secretion, and smooth muscle contraction [PMID:18658048, PMID:22284188, PMID:20385802, PMID:18260825].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing RGS4 as a GAP for Gi-family Gα subunits answered the fundamental question of what biochemical activity RGS proteins possess, revealing they accelerate GTP hydrolysis ≥40-fold and prefer the transition-state conformation of Gα.\",\n      \"evidence\": \"In vitro GTPase assays with purified recombinant proteins and AlF4⁻ transition-state trapping\",\n      \"pmids\": [\"8756726\", \"8910288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity among Gi subfamily members not fully resolved\", \"Mechanism of transition-state stabilization not yet structurally defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The crystal structure of the RGS4–Giα1 complex revealed that the RGS domain contacts all three Gα switch regions without contributing catalytic residues to the active site, establishing transition-state stabilization as the dominant catalytic mechanism and distinguishing it from Ras GAPs.\",\n      \"evidence\": \"X-ray crystallography at 2.8 Å resolution of RGS4–Giα1·GDP·AlF4⁻ complex, validated by structure-guided mutagenesis\",\n      \"pmids\": [\"9108480\", \"9371764\", \"9430692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Asn-128 directly contacts catalytic water remained debated\", \"Structure of free RGS4 and induced-fit changes unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that RGS4 also acts as a GAP for Gαq and blocks PLC-β activation—partly by effector-site occlusion—expanded its substrate range beyond Gi to include Gq-mediated signaling pathways.\",\n      \"evidence\": \"In vitro GTPase and PLC reconstitution assays, cellular MAPK and inositol phosphate assays in COS-7 cells\",\n      \"pmids\": [\"9012799\", \"9115254\", \"9177187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of GAP versus effector antagonism in intact cells unclear\", \"G12/13 family substrates not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"The N-terminal amphipathic domain was shown to be essential for plasma membrane targeting, receptor-selective inhibition, and high-potency GAP function, separating the catalytic core from the targeting/selectivity module.\",\n      \"evidence\": \"N-terminal deletion mutants in reconstituted systems and yeast pheromone assay; GFP localization; palmitoylation site mutagenesis\",\n      \"pmids\": [\"9856989\", \"9576926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether palmitoylation is required in mammalian cells remained unresolved\", \"Structural basis of receptor selectivity unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"RGS4 was shown to inhibit metabotropic glutamate receptor signaling in neurons, providing the first evidence of its physiological role in regulating Gq-coupled neurotransmission.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology for mGluR1a/5a; patch clamp in hippocampal CA1 neurons\",\n      \"pmids\": [\"9437012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous RGS4 contribution versus other RGS family members not dissected\", \"In vivo neuronal role not yet tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Cardiac-specific transgenic overexpression demonstrated that RGS4 inhibits pressure-overload-induced ventricular hypertrophy in vivo, establishing its physiological role as a brake on Gq-dependent hypertrophic signaling in the heart.\",\n      \"evidence\": \"Transgenic mouse model with transverse aortic constriction; hemodynamics and fetal gene expression analysis; GAP-dead N128A mutant as negative control in cardiomyocytes\",\n      \"pmids\": [\"10487771\", \"9918533\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Loss-of-function cardiac phenotype not yet examined\", \"Specific Gα substrates in cardiomyocytes not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"NMR structure of free RGS4 revealed an induced-fit conformational change upon Gα binding, and the N-end rule degradation pathway was identified as the mechanism controlling RGS4 protein turnover, linking its Cys-2 residue to arginylation and proteasomal targeting.\",\n      \"evidence\": \"Solution NMR spectroscopy; expression-cloning screen in reticulocyte lysate with N-terminal sequencing and mutagenesis\",\n      \"pmids\": [\"10852703\", \"10783390\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ubiquitin ligase not yet established\", \"Whether Cys-2 oxidation is regulated in vivo unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic identification of ATE1, UBR1, and UBR2 as the arginyl-transferase and E3 ligases targeting RGS4 completed the molecular pathway of N-end rule degradation and revealed oxygen/NO-dependent Cys-2 oxidation as a regulatory switch.\",\n      \"evidence\": \"ATE1−/−, UBR1/UBR2 knockout mouse cells; pulse-chase stability assays; in vivo ubiquitination\",\n      \"pmids\": [\"16217033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological oxygen sensing context not fully defined\", \"Whether other post-translational modifications cooperate with N-end rule pathway\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"RGS4 was found to pre-couple with GPCR–Kir3 channel complexes via direct receptor interaction and to be regulated by PKA/PKG phosphorylation at Ser-52, revealing how scaffolding and kinase signaling tune its GAP activity at the plasma membrane.\",\n      \"evidence\": \"Co-immunoprecipitation and FRET in live cells; in vitro phosphorylation; S52A mutant; GTPase/PLC assays in smooth muscle cells\",\n      \"pmids\": [\"16973624\", \"17185339\", \"16885398\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GPCR–RGS4 interaction not resolved\", \"Whether phosphorylation and palmitoylation are coordinated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"RGS4 knockout mice revealed enhanced parasympathetic bradycardia and impaired IKACh desensitization in sinoatrial node myocytes, establishing RGS4 as a non-redundant regulator of cardiac pacemaking.\",\n      \"evidence\": \"RGS4−/− mouse; in vivo telemetry; ex vivo perfused heart; SAN myocyte patch clamp\",\n      \"pmids\": [\"18658048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redundancy with other cardiac RGS proteins (RGS6, RGS10) not fully dissected\", \"Human cardiac relevance not directly tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Beta-cell-specific RGS4 deletion demonstrated that RGS4 tonically suppresses M3 muscarinic receptor/Gq-mediated insulin secretion, identifying it as a physiological regulator of glucose homeostasis.\",\n      \"evidence\": \"siRNA in MIN6 cells; RGS4-deficient islets; beta-cell-specific knockout mice; calcium imaging and insulin secretion in vivo\",\n      \"pmids\": [\"20385802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RGS4 regulates GLP-1R or other incretin receptor pathways in beta cells\", \"Compensatory RGS family member expression not assessed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"RGS4 knockout restored endocannabinoid-dependent long-term depression in dopamine-depleted striatum and reduced motor impairment in a Parkinson's model, establishing RGS4 as a link between D2/A2A receptor signaling and synaptic plasticity relevant to basal ganglia function.\",\n      \"evidence\": \"RGS4−/− mouse; electrophysiological LTD recording; 6-OHDA Parkinson's model; pharmacological pathway dissection\",\n      \"pmids\": [\"22284188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific RGS4 contribution (direct vs indirect pathway MSNs) not isolated\", \"Downstream eCB synthesis mechanism not fully defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Rab GTPase-dependent trafficking of RGS4 between plasma membrane and endosomes was mapped, and NO-induced proteasomal degradation of RGS4 was shown to derepress Gβγ/PI3Kγ/AKT signaling to promote cardiomyocyte hypertrophy, integrating membrane trafficking and degradation as regulatory mechanisms.\",\n      \"evidence\": \"Dominant-active/negative Rab constructs with live-cell imaging; transgenic PlGF/RGS4/eNOS-KO mouse models; NOS inhibitor studies\",\n      \"pmids\": [\"23733193\", \"23454748\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Rab-mediated trafficking studied primarily with overexpressed constructs\", \"Whether endosomal RGS4 retains GAP activity unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"RGS4 deletion predisposed to atrial fibrillation via enhanced Gαq/11-IP3-mediated Ca²⁺ release, and a selective small-molecule RGS4 inhibitor validated RGS4 as a druggable target in cardiac and neurological disease models.\",\n      \"evidence\": \"RGS4−/− mouse with atrial burst pacing and Ca²⁺ imaging; CCG-203769 selectivity panel; in vivo bradycardia and akinesia assays\",\n      \"pmids\": [\"26088132\", \"25844489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term in vivo pharmacology and off-target effects of CCG-203769 not characterized\", \"Whether RGS4 loss-of-function variants cause human arrhythmia unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of RGS4's direct interaction with GPCRs, the precise mechanism by which Cys-2 oxidation is sensed in vivo, and whether RGS4 functions at endosomes remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of RGS4 bound to any GPCR\", \"Oxygen/NO sensing mechanism for Cys-2 oxidation not reconstituted in defined system\", \"Functional significance of endosomal RGS4 pool not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 7, 9, 15, 18, 19]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 1, 2, 6, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 11, 22, 23, 27, 38]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 22, 27]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [38]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 7, 10, 19, 26, 27, 32, 33, 35]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [10, 19, 25, 26, 31, 35, 36]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [17, 24, 29, 34, 37]}\n    ],\n    \"complexes\": [\n      \"GPCR-Kir3 channel signaling complex\",\n      \"A1R/neurabin/RGS4 complex\"\n    ],\n    \"partners\": [\n      \"GNAI1\",\n      \"GNAI2\",\n      \"GNAO1\",\n      \"GNAQ\",\n      \"KCNJ3\",\n      \"ATE1\",\n      \"UBR1\",\n      \"PPP1R9A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}